<DOC>
	<DOCNO>NCT02808039</DOCNO>
	<brief_summary>ass whether cessation 12 month DAPT regimen contain Ticagrelor result hyperreactive phase platelet function</brief_summary>
	<brief_title>Is There Transient Rebound Effect Platelet Reactivity Following Cessation Dual Antiplatelet Therapy With Ticagrelor - Single Center Prospective Observational Trial</brief_title>
	<detailed_description>study compose cohort patient , complete 12 month DAPT Ticagrelor ( standard recommend dose ACS - 90 mg BID ) , experience clinical adverse event time period discontinue Ticagrelor . We intend measure platelet reactivity patient 4 time point - prior cessation Ticagrelor ( i.e . still DAPT ) 1,4 12 week post discontinuation therapy . There control group .</detailed_description>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Age &gt; 18 underwent coronary stent implantation due ACS complete 12 month DAPT regimen contain Ticagrelor standard dose ( 90 mg BID ) ischemic bleed event Ticagrelor Ticagrelor associate adverse effect plan continuation Ticagrelor 12months post stenting accord judgment attend physician . Unable make informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>